1. A system for detecting deviation from a normal flight regime, the system comprising:
at least one aircraft information system located on an aircraft for detecting an aircraft position variable;
a processing system on the aircraft configured to determine whether an aircraft condition variable is within a predefined tolerance of a predefined normal status for the aircraft condition variable, the processing system including an output device configured to transmit a signal indicative of a deviation from the predefined normal status; and
a communication system configured to communicate the signal indicative of the deviation from the predefined normal status from the aircraft to a receiving station located external to the aircraft using a Mode-S transponder system and the signal indicative of the deviation from the predefined normal status is transmitted as a modified Mode-S signal.
2. The system of claim 1, wherein the aircraft information system includes at least one of an attitude heading reference system an air data computer, a flight control computer and an auto pilot system.
3. The system of claim 1, wherein the signal indicative of a deviation from the predefined normal status is broadcast using a VHF radio system.
4. The system of claim 1, wherein the signal indicative of the deviation from the predefined normal status includes the aircraft condition variable.
5. The system of claim 1, wherein the aircraft information system is a vertical speed indicator.
6. The system of claim 5, wherein the aircraft condition variable is a current rate of ascent for the aircraft.
7. The system of claim 1, wherein the processing system is part of the aircraft information system.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
What is claimed is:
1. Substantially pure CTGF polypeptide having an amino acid sequence set forth in SEQ ID NO:2, or functional fragments thereof.
2. An antibody that binds to a polypeptide as set forth in SEQ ID NO:2, or fragments thereof.
3. The antibody of claim 2, wherein the antibody is polyclonal.
4. The antibody of claim 2, wherein the antibody is monoclonal.
5. The antibody of claim 2, wherein the antibody is detectably labeled.
6. The antibody of claim 5, wherein the detectable label is selected from the group consisting of a radioisotope, a fluorescent compound, a bioluminescent compound, a chemiluminescent compound, a metal chelator or an enzyme.